2.3. Inclusion and Exclusion Criteria
developmental impairments, cleft palate, allergic, malignancy, congenital malformations, malabsorption/metabolic disorders
PERSISTENT DIARRHEA, CEREBRAL PALSY, GASTROINTESTINAL TRACT DISORDERS, SEVERE MALNUTRITION
All children (24–48 months) at the time of enrollment were included in the trial. However, children with severe malnutrition, i.e., Mid Upper Arm Circumference < 11.5 cm (MUAC), congenital malformations identified at the baseline or severe developmental impairments such as cerebral palsy, those with malabsorption/metabolic disorders or malignancy, as well as those children who were allergic to the supplement ingredients, had persistent diarrhea, or who were unable to take MNP (e.g., cleft palate), and children who had been regularly taking other supplements or had any known gastrointestinal tract disorders, were excluded from the study (